Oneview Healthcare, a Dublin, Ire.-based health IT software maker focused on patient engagement and clinical workflows, said it recently raised $7 million that will help it expand in the “critical North American” hospital market.
The $7 million is the third round of equity for Oneview since January 2013, having raised a total of $20 million, mostly from Australian investors. The new funds will be used “primarily to facilitate the expansion of sales, marketing, project management and implementation resources,” in North America, the company said in a release.
Oneview said it just completed deployment of its products at the “high-profile” $1.52 billion UCSF Mission Bay Campus in San Francisco, where its software is powering over 850 devices in three hospitals: UCSF Benioff Children’s Hospital, UCSF Bakar Cancer Hospital and the UCSF Betty Irene Moore Women’s Hospital.
Started in 2007, the company is headed by CEO James Fitter and was founded by president Mark McCloskey. The company also serves facilities in Australia and the Middle East.
As part of the expansion of U.S. resources, Samir Batra joined Oneview in San Francisco as vice president of patient engagement. Badra joins from his most recent role as senior director of healthcare solutions for CareInSync, which was recently acquired by Zynx Health. in Santa Clara.
In addition, Walter Groszewski joined in New York as vice president of the North East region. He joins from his most recent role at Awarepoint where he was vice president in the sales organization.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
